Kiguba, Ronald http://orcid.org/0000-0002-2636-4115
Zakumumpa, Henry
Ndagije, Helen B.
Mwebaza, Norah
Ssenyonga, Ronald
Tregunno, Phil
Harrison, Kendal
Pirmohamed, Munir
Funding for this research was provided by:
Medical Research Council (MR/V03510X/1)
Makerere University Research & Innovations Fund
National Drug Authority, Uganda
Article History
Accepted: 26 March 2023
First Online: 25 April 2023
Declarations
:
: The Medical Research Council (MR/V03510X/1), Makerere University Research & Innovations Fund (N/A) and National Drug Authority (N/A) gave financial support to this project.
: Ronald Kiguba and Munir Pirmohamed obtained funding from the MRC; however, the funder had no role in drafting this paper. Ronald Kiguba, Henry Zakumumpa, Helen B. Ndagije, Norah Mwebaza, Ronald Ssenyonga, Phil Tregunno and Kendal Harrison declare that they have no conflicts of interest. Munir Pirmohamed has received partnership funding for the following: MRC Clinical Pharmacology Training Scheme (co-funded by MRC and Roche, UCB, Eli Lilly and Novartis). He also has unrestricted educational grant support for the UK Pharmacogenetics and Stratified Medicine Network from Bristol-Myers Squibb. He has developed an HLA genotyping panel with MC Diagnostics, but does not benefit financially from this. He is part of the IMI Consortium ARDAT (ExternalRef removed). None of this funding MP received is related to the current paper.
: This study received ethical approval from the School of Biomedical Sciences Research and Ethics Committee, College of Health Sciences, Makerere University (SBS-REC-720) and Uganda National Council for Science and Technology (HS1366ES).
: Study participants gave written informed consent (Supplementary material).
: Study participants gave permission and they will not be identifiable.
: The data that support these findings will be made available by the authors on reasonable request.
: Not applicable.
: RK and HZ designed the study. RK drafted the manuscript. RK, HZ, HBN, NM, RS, PT, KH and MP critically reviewed and revised the final version of the manuscript. All authors read and approved the final manuscript.